Tranxene
- Product NDC
- 55292-304
- 11-digit product format
- 552920304
- Labeler code
- 55292
- Product ID
- 55292-304_1aad278c-14c5-4b8a-ad70-ce61a220936e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- clorazepate dipotassium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Recordati Rare Diseases, Inc.
- Application
- NDA017105
- Marketing category
- NDA
- Marketing start
- 1972-06-23
- Marketing end
- 2023-01-31
- Substance
- CLORAZEPATE DIPOTASSIUM
- Active strength
- 8 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55292-304-01 | 55292030401 | 100 TABLET in 1 BOTTLE (55292-304-01) | 100 tablet | 1972-06-23 | 2023-01-31 | No | No | Current |